BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Seres Therapeutics Inc. (NASDAQ:MCRB)

2 posts

Biotech NewsSeres Therapeutics (MCRB): The $100M Microbiome Gem Flying Under Wall Street’s Radar

  • BioTech Health X
  • July 22, 2025
Seres Therapeutics, Inc. (NASDAQ:MCRB) is a pioneering biotechnology company at the forefront of developing microbiome therapeutics—a groundbreaking class…
0 Shares
0
0
0
0
0
0
0

Biotech NewsCould Seres Therapeutics (MRCB) Replace Antibiotics? This Biotech’s Next Drug Could Do It

  • BioTech Health X
  • June 25, 2025
Seres Therapeutics (MRCB), based in Cambridge, Massachusetts, stands at the vanguard of the live biotherapeutics revolution. Since its…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • From NeuroBo to MetaVia (MTVA): This Biotech Just Went All-In on Obesity and Liver Disease
  • Alterity Therapeutics (ATHE) is One FDA Meeting Away From a Major Breakout
  • Liminatus Pharma (LIMN) Might Be the Most Disruptive Micro-Cap on NASDAQ
  • Thermo Fisher (TMO) Is Everywhere—And That’s Exactly Why It’s Winning
  • Krystal Biotech (KRYS) Just Changed Gene Therapy Forever—Smart Investors Are Paying Attention
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • July 23, 2025
    From NeuroBo to MetaVia (MTVA): This Biotech Just Went All-In on Obesity and Liver Disease
    • July 23, 2025
    Alterity Therapeutics (ATHE) is One FDA Meeting Away From a Major Breakout
    • July 23, 2025
    Liminatus Pharma (LIMN) Might Be the Most Disruptive Micro-Cap on NASDAQ
    • July 23, 2025
    Thermo Fisher (TMO) Is Everywhere—And That’s Exactly Why It’s Winning
    • July 22, 2025
    Krystal Biotech (KRYS) Just Changed Gene Therapy Forever—Smart Investors Are Paying Attention
Recent Posts
  • Telesurgery Is Here—and Intuitive Surgical (ISRG) Owns It
    • July 22, 2025
  • Medpace (MEDP) Just Soared 50%—Is This the Most Underrated Biotech Play of 2025?
    • July 22, 2025
  • TransMedics (TMDX) Could Be the Tesla of Transplants — Here’s Why Investors Are Paying Attention
    • July 21, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (263)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top